CROI 2013: Health Insurance & Durable Viral Suppression
The Particulars: Policies to improve the health of patients with HIV may be guided by nationally...
Read MoreMar 6, 2013
The Particulars: Policies to improve the health of patients with HIV may be guided by nationally...
Read MoreMar 6, 2013
The Particulars: Previous research suggests that as many as 70% of patients with HIV smoke...
Read MoreMar 6, 2013
The Particulars: Since 2006, the CDC has recommended routine opt-out HIV testing for early...
Read MoreMar 6, 2013
ATLANTA – All-oral regimens under investigation for hepatitis C virus (HCV) were able to cure up...
Read MoreMar 6, 2013
ATLANTA – A protease inhibitor being investigated in patients co-infected with the hepatitis C...
Read MoreMar 6, 2013
Results from a large-scale HIV prevention trial among African women known as VOICE (Vaginal and...
Read MoreMar 6, 2013
CDC scientists will be presenting more than 40 abstracts at CROI 2013. Several studies that may be...
Read MoreMar 6, 2013
Very early antiretroviral treatment may limit the size of the HIV reservoir in adults and...
Read MoreMar 6, 2013
ATLANTA — A large study to determine if pre-exposure prophylaxis could prevent HIV transmission...
Read MoreMar 6, 2013
ATLANTA – Adding an extra drug to a promising hepatitis C (HCV) regimen increased its efficacy –...
Read MoreMar 6, 2013
ATLANTA – Putting HIV controllers — who ordinarily don’t need therapy — on highly active...
Read MoreMar 6, 2013
ATLANTA — Researchers reported here that a child born with HIV infection and treated in infancy...
Read MoreFeb 26, 2013
The U.S. Food and Drug Administration today approved Osphena (ospemifene) to treat women...
Read MoreFeb 25, 2013
The U.S. Food and Drug Administration today expanded the approved use of Stivarga (regorafenib) to...
Read MoreFeb 22, 2013
The U.S. Food and Drug Administration today approved Kadcyla (ado-trastuzumab emtansine), a new...
Read MoreFeb 14, 2013
The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the...
Read MoreFeb 8, 2013
The U.S. Food and Drug Administration today approved Pomalyst (pomalidomide) to treat patients...
Read MoreFeb 8, 2013
More than a third of patients who suffer a major bleeding in the brain and have their life support...
Read MoreFeb 8, 2013
About one-third of American infants and children who suffer bleeding into brain tissue may later...
Read More